Verity Saunders

Ms, BSc(Hons)

  • 1453 Citations
  • 15 h-Index
20052020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Public Profile

My role as Laboratory Manager is to oversee the operations of the Precision Medicine Theme Level 5 North PC2 Laboratory to ensure it is a functional and harmonious working environment for all of the researchers. As a Clinical Research Scientist with the Leukaemia Research Group, I process haematopoietic samples collected on various CML and ALL clinical study protocols. I perform Correlative Science Studies for trials, data entry and analysis, and result verification. I manage our extensive CML and ALL ultracold and cryogenic collections of clinical specimens for research. I am involved with a number of research projects (namely Treatment-free Remission in CML) and provide technical assistance to our post-doctoral researchers and contribute to manuscripts for scientific publication.

Education/Academic qualification

Bachelor of Science (Honours), University of Adelaide

Mar 1997Dec 2000

Keywords

  • Chronic Myeloid Leukaemia
  • Clinical Trials
  • CML
  • Acute Lymphoblastic Leukaemia
  • ALL
  • Laboratory management
  • Clinical Research
  • biobanking
  • PC2 lab
  • Haematology

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 1453 Citations
  • 15 h-Index
  • 22 Article
  • 7 Letter

Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remission

Pagani, I. S., Dang, P., Saunders, V. A., Grose, R., Shanmuganathan, N., Kok, C. H., Carne, L., Rwodzi, Z., Watts, S., McLean, J., Braley, J., Altamura, H., Yeung, D. T., Branford, S., Yong, A. S. M., White, D. L., Hughes, T. P. & Ross, D. M., Apr 2020, In : Leukemia. 34, 4, p. 1052-1061 10 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)
3 Citations (Scopus)

Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia

Ross, D. M., Pagani, I., Irani, Y., Clarson, J., Gray, T., Dang, Y., McLean, J., Saunders, V., Carne, L., Reynolds, J., Ritchie, D. S., White, D., Branford, S., Hughes, T. & Yong, A., 1 Aug 2019, In : British Journal of Haematology. 186, 3, p. e56-e60

Research output: Contribution to journalLetter

4 Citations (Scopus)

BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia

Pagani, I. S., Dang, P., Kommers, I. O., Goyne, J. M., Nicola, M., Saunders, V. A., Braley, J., White, D. L., Yeung, D. T., Branford, S., Hughes, T. P. & Ross, D. M., 30 Nov 2018, In : Haematologica. 103, 12, p. 2026-2032 7 p.

Research output: Contribution to journalArticle

Open Access
13 Citations (Scopus)

Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells

on behalf of the Australasian Leukaemia and Lymphoma Group (ALLG), 1 Dec 2018, In : Leukemia. 32, 12, p. 2572-2579 8 p.

Research output: Contribution to journalArticle

14 Citations (Scopus)